When a development program misses projected timelines, the explanation often centers on regulatory review. FDA feedback … Why Regulatory Delays Are Only Part of the U.S. Clinical Trial ProblemRead more
FDA approvals
Common Clinical Trial Mistakes Pharma Companies Keep Repeating
Despite decades of regulatory guidance, expanded access to data, and repeated public postmortems of failed programs, … Common Clinical Trial Mistakes Pharma Companies Keep RepeatingRead more
FDA Fast Track: A New Era for Pharma Marketing
Explore how FDA fast track designations are reshaping pharma launch strategies with real-world examples and powerful … FDA Fast Track: A New Era for Pharma MarketingRead more